Provided by Tiger Fintech (Singapore) Pte. Ltd.

Stoke Therapeutics, Inc.

8.39
-0.4800-5.41%
Volume:849.89K
Turnover:7.08M
Market Cap:444.39M
PE:-4.06
High:8.95
Open:8.95
Low:8.05
Close:8.87
Loading ...

Stoke Therapeutics Shares up 3.5% After Co Enters Partnership With Biogen to Develop, Sell Epilepsy Drug

THOMSON REUTERS
·
18 Feb

Biogen Shares up About 1%

THOMSON REUTERS
·
18 Feb

Stoke Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $47 From $35

THOMSON REUTERS
·
18 Feb

Biogen, Stoke Therapeutics Set Dravet Syndrome Collaboration

Dow Jones
·
18 Feb

Stoke Therapeutics and Biogen in pact for treatment for severe form of epilepsy

Dow Jones
·
18 Feb

Stoke Therapeutics And Biogen In Pact For Treatment For Severe Form Of Epilepsy -- MarketWatch

Dow Jones
·
18 Feb

Biogen, Stoke Therapeutics announce zorevunersen commercialization agreement

TIPRANKS
·
18 Feb

Biogen Inc - Phase 3 Study of Zorevunersen to Initiate in Q2 2025

THOMSON REUTERS
·
18 Feb

Biogen Inc - Stoke Retains Exclusive Rights for Zorevunersen in US, Canada, Mexico; Biogen Gets Rest of World

THOMSON REUTERS
·
18 Feb

Biogen and Stoke Therapeutics Enter Into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated With Refractory Seizures and Neurodevelopmental Impairments

THOMSON REUTERS
·
18 Feb

Biogen Inc - Stoke to Receive $165M Upfront, up to $385M in Milestones

THOMSON REUTERS
·
18 Feb

Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?

Zacks
·
05 Feb

The 13% return this week takes Stoke Therapeutics' (NASDAQ:STOK) shareholders one-year gains to 116%

Simply Wall St.
·
27 Jan

Possible Signal As Stoke Therapeutics Insiders Sell US$523k In Stock

Simply Wall St.
·
22 Jan

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

Zacks
·
17 Jan

Stoke Therapeutics negative reaction after STK-001 update overdone, says Chardan

TIPRANKS
·
08 Jan